• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Research Brief on (R)-2-Amino-2-cyclohexylethanol Hydrochloride (CAS: 85711-14-4): Recent Advances and Applications

(R)-2-Amino-2-cyclohexylethanol hydrochloride (CAS: 85711-14-4) is a chiral amino alcohol derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including antiviral agents, enzyme inhibitors, and chiral ligands for asymmetric catalysis. Recent studies have highlighted its potential in drug discovery and development, particularly in the context of targeting neurological disorders and infectious diseases.

A 2023 study published in the Journal of Medicinal Chemistry explored the use of (R)-2-Amino-2-cyclohexylethanol hydrochloride as a building block for the synthesis of novel protease inhibitors. The research demonstrated that derivatives of this compound exhibit potent inhibitory activity against SARS-CoV-2 main protease (M^pro), with IC₅₀ values in the low micromolar range. The study employed molecular docking and kinetic assays to elucidate the binding mechanisms, revealing that the cyclohexyl moiety enhances hydrophobic interactions with the protease active site.

In another recent investigation, researchers focused on the application of (R)-2-Amino-2-cyclohexylethanol hydrochloride in the development of gamma-aminobutyric acid (GABA) receptor modulators. The compound's chiral center and structural flexibility make it an ideal scaffold for designing selective GABA_A receptor ligands. Preclinical studies in rodent models showed that optimized derivatives could potentially address anxiety and epilepsy disorders with reduced side effects compared to existing therapeutics.

From a synthetic chemistry perspective, advancements have been made in the enantioselective preparation of (R)-2-Amino-2-cyclohexylethanol hydrochloride. A 2024 Nature Communications paper described a biocatalytic approach using engineered transaminases, achieving >99% enantiomeric excess (ee) and high yield (92%) under mild reaction conditions. This green chemistry method significantly improves upon traditional resolution techniques and aligns with the pharmaceutical industry's push toward sustainable manufacturing processes.

The compound's physicochemical properties have also been reevaluated using modern analytical techniques. Differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) studies confirmed its polymorphic behavior, which has implications for formulation development. Notably, the hydrochloride salt form (CAS: 85711-14-4) demonstrates superior solubility and stability profiles compared to the free base, making it the preferred form for pharmaceutical applications.

Looking forward, (R)-2-Amino-2-cyclohexylethanol hydrochloride continues to show promise as a versatile chiral synthon. Ongoing research is exploring its incorporation into metal-organic frameworks (MOFs) for drug delivery applications and its potential as a template for designing novel antimicrobial peptides. The compound's unique structural features and demonstrated biological activities position it as a valuable asset in medicinal chemistry pipelines across multiple therapeutic areas.

• 24629-25-2(2-Amino-3-methylpentan-1-ol)
• 99839-72-2(2-amino-2-cyclohexylethan-1-ol)
• 131288-67-0((2S)-2-amino-3-cyclohexylpropan-1-ol)
• 133736-94-4(L-Isoleucinol hydrochloride)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)